Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

BC110118

Ovarian cancer tissue array, including TNM and pathology grade, 72 cases/72 cores, replacing BC11012
Unstained: $185.00 Add to Cart
H&E (BC110118s*): $185.00 Add to Cart

Microarray Panel:Ovary tumor tissue microarray, containing 42 cases of adenocarcinoma, 3 clear cell carcinoma, 2 endodermal sinus carcinoma, 3 granular cell tumor, 3 dysgerminoma, 1 theca folliculi tumor, 8 metastatic carcinoma, 1 squamous cell carcinoma and 9 adjacent normal ovary tissue, single core per case
Cores:72
Cases:72
Layout:9 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789 
A Ova Ova Ova Ova Ova Ova Ova Ova Ova  
B Ova Ova Ova Ova Ova Ova Ova Ova Ova  
C Ova Ova Ova Ova Ova Ova Ova Ova Ova  
D Ova Ova Ova Ova Ova Ova Ova Ova Ova  
E Ova Ova Ova Ova Ova Ova Ova Ova Ova  
F Ova Ova Ova Ova Ova Ova Ova Ova Ova  
G Ova Ova Ova Ova Ova Ova Ova Ova Ova  
H Ova Ova Ova Ova Ova Ova Ova Ova Ova Marked point
Legend: Ova - Ovary

- Malignant tumor, - Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IIIc), - Malignant tumor (stage IIa), - Malignant tumor (stage IV), - Malignant tumor (stage Ia), - Malignant tumor (stage Ic), - Malignant tumor (stage Iib), - Metastasis, - NAT

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 53 Ovary Serous papillary adenocarcinoma 1 IV T2N0M1 Malignant
A2 2 F 42 Ovary Serous papillary adenocarcinoma 1 I T1N0M0 Malignant
A3 3 F 26 Ovary Serous papillary adenocarcinoma 1 Ic T1cN0M0 Malignant
A4 4 F 51 Ovary Serous papillary adenocarcinoma 1 IIIc T3cN1M0 Malignant
A5 5 F 69 Ovary Mucinous adenocarcinoma 1 Ia T1aN0M0 Malignant
A6 6 F 48 Ovary Serous papillary adenocarcinoma 2 I T1N0M0 Malignant
A7 7 F 57 Ovary Serous papillary adenocarcinoma 2 Ic T1cN0M0 Malignant
A8 8 F 50 Ovary Serous papillary adenocarcinoma 2 II T2N0M0 Malignant
A9 9 F 47 Ovary Serous papillary adenocarcinoma 2 I T1N0M0 Malignant
B1 10 F 56 Ovary Serous papillary adenocarcinoma 2 II T2N0M0 Malignant
B2 11 F 35 Ovary Serous papillary adenocarcinoma 2 Ia T1aN0M0 Malignant
B3 12 F 26 Ovary Serous papillary adenocarcinoma 1 IIIc T3cN1M0 Malignant
B4 13 F 22 Ovary Serous papillary adenocarcinoma 1 Iib T2bN0M0 Malignant
B5 14 F 53 Ovary Serous papillary adenocarcinoma 2 Ic T1cN0M0 Malignant
B6 15 F 32 Ovary Serous papillary adenocarcinoma 2 I T1N0M0 Malignant
B7 16 F 46 Ovary Serous adenocarcinoma 2 Ia T1aN0M0 Malignant
B8 17 F 50 Ovary Serous adenocarcinoma with necrosis 2–3 Ia T1aN0M0 Malignant
B9 18 F 49 Ovary Serous adenocarcinoma with necrosis 2–3 Ia T1aN0M0 Malignant
C1 19 F 52 Ovary Mucinous adenocarcinoma 2 I T1N0M0 Malignant
C2 20 F 38 Ovary Serous papillary adenocarcinoma 3 IIIc T3bN1M0 Malignant
C3 21 F 49 Ovary Serous papillary adenocarcinoma 2 II T2N0M0 Malignant
C4 22 F 58 Ovary Serous papillary adenocarcinoma 3 I T1N0M0 Malignant
C5 23 F 50 Ovary Serous adenocarcinoma 3 I T1N0M0 Malignant
C6 24 F 52 Ovary Serous adenocarcinoma with necrosis 3 IIa T2aN0M0 Malignant
C7 25 F 65 Ovary Serous adenocarcinoma 3 II T2N0M0 Malignant
C8 26 F 46 Ovary Serous adenocarcinoma (sparse) 3 IIIc T2cN1M0 Malignant
C9 27 F 54 Ovary Serous adenocarcinoma with necrosis 3 IIIc T3cN0M0 Malignant
D1 28 F 55 Ovary Serous adenocarcinoma 3 II T2N0M0 Malignant
D2 29 F 42 Ovary Serous adenocarcinoma 3 IIIc T3cN1M0 Malignant
D3 30 F 47 Ovary Serous adenocarcinoma 3 Ic T1cN0M0 Malignant
D4 31 F 51 Ovary Serous adenocarcinoma 3 I T1N0M0 Malignant
D5 32 F 57 Ovary Serous adenocarcinoma 3 IIIc T3cN1M0 Malignant
D6 33 F 46 Ovary Serous adenocarcinoma 3 IIIc T3aN1M0 Malignant
D7 34 F 42 Ovary Serous adenocarcinoma 3 II T2N0M0 Malignant
D8 35 F 49 Ovary Serous adenocarcinoma 3 II T2N0M0 Malignant
D9 36 F 52 Ovary Serous adenocarcinoma 3 II T2N0M0 Malignant
E1 37 F 49 Ovary Serous adenocarcinoma 3 I T1N0M0 Malignant
E2 38 F 52 Ovary Serous adenocarcinoma 3 Ia T1aN0M0 Malignant
E3 39 F 49 Ovary Serous adenocarcinoma 3 I T1N0M0 Malignant
E4 40 F 39 Ovary Endometrioid adenocarcinoma 1 Ia T1aN0M0 Malignant
E5 41 F 55 Ovary Endometrioid adenocarcinoma 2 I T1N0M0 Malignant
E6 42 F 48 Ovary Clear-cell carcinoma – II T2N0M0 Malignant
E7 43 F 43 Ovary Clear-cell carcinoma (sparse) – I T1N0M0 Malignant
E8 44 F 40 Ovary Clear-cell carcinoma – I T1N0M0 Malignant
E9 45 F 27 Ovary Endodermal sinus carcinoma – I T1N0M0 Malignant
F1 46 F 44 Ovary Granular cell tumor – Ic T1cN0M0 Malignant
F2 47 F 57 Ovary Granular cell tumor – I T1N0M0 Malignant
F3 48 F 43 Ovary Granular cell tumor – I T1N0M0 Malignant
F4 49 F 13 Ovary Dysgerminoma – Ia T1aN0M0 Malignant
F5 50 F 35 Ovary Dysgerminoma – Ia T1aN0M0 Malignant
F6 51 F 41 Ovary Dysgerminoma – I T1N0M0 Malignant
F7 52 F 34 Ovary Serous papillary adenocarcinoma (sparse carcinoma) 1 Ia T1aN0M0 Malignant
F8 53 F 48 Ovary Theca folliculi tumor (malignant) – III T3N0M0 Malignant
F9 54 F 24 Ovary Endodermal sinus carcinoma – II T2N0M0 Malignant
G1 55 F 48 Ovary Metastatic adenocarcinoma – – – Metastasis
G2 56 F 40 Ovary Metastatic adenocarcinoma – – – Metastasis
G3 57 F 38 Ovary Metastatic adenocarcinoma – – – Metastasis
G4 58 F 55 Ovary Metastatic adenocarcinoma – – – Metastasis
G5 59 F 66 Ovary Metastatic adenocarcinoma – – – Metastasis
G6 60 F 30 Ovary Metastatic adenocarcinoma – – – Metastasis
G7 61 F 53 Ovary Metastatic adenocarcinoma – – – Metastasis
G8 62 F 31 Ovary Metastatic adenocarcinoma – – – Metastasis
G9 63 F 62 Ovary Malignant change of benign teratoma (squamous cell carcinoma II) – – – Malignant
H1 64 F 39 Ovary Cancer adjacent normal ovary tissue – – – NAT
H2 65 F 49 Ovary Cancer adjacent normal ovary tissue – – – NAT
H3 66 F 48 Ovary Cancer adjacent normal ovary tissue – – – NAT
H4 67 F 42 Ovary Cancer adjacent normal ovary tissue – – – NAT
H5 68 F 41 Ovary Cancer adjacent normal ovary tissue – – – NAT
H6 69 F 53 Ovary Cancer adjacent normal ovary tissue – – – NAT
H7 70 F 20 Ovary Cancer adjacent normal ovary tissue – – – NAT
H8 71 F 15 Ovary Cancer adjacent normal ovary tissue – – – NAT
H9 72 F 19 Ovary Cancer adjacent normal ovary tissue – – – NAT
– – F 55 liver Hepatocellular liver cancer (tissue marker) 3 T3N0M0 Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal